Webinar Series:
In-Silico-First - Accelerating Drug Development with MultiomicsAI

As drug development continues to accelerate, there is a risk that important insights will be lost if we rely solely on wet lab repetition. An in-silico-first approach combines genomics, transcriptomics, proteomics and real-world data in a unified, AI-driven pipeline that identifies important biological signals at an early phase, de-risking decisions and accelerating timelines. knowing01's MultiomicsAI platform links and contextualizes fragmented data at scale, turning them into investor-ready insights that move the right candidates through early-phase milestones faster and with greater certainty.

Join our upcoming webinar to learn how AI-powered Multiomics is redefining R&D, helping scientists overcome traditional limitations, and paving the way for the next wave of therapeutic innovations.

Join our Quick-View 15-minute Webinar!

When?    Thursday, 22 May 2025, at 5pm-5:15pm CEST (11am-11:15pm EDT)

Duration?  15 min

Where?   Online!

Details

Dr. Nikola Müller, our founder and CEO, and Karolina Worf, Online Content Manager, will talk about "In-Silico-First - Accelerating Drug Development with MultiomicsAI".